Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate for contraception
NCT03296098Phase 2Withdrawn
- Sponsor
- Premier Research
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ulipristal, sponsored by Premier Research. Primary endpoint: Pearl Index at 6 months. Planned start Dec 2020; status: withdrawn.
02
Drugs
ulipristal
Beyond the preview
Go deeper on NCT03296098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296098.